Literature DB >> 17085281

Structure and function of C1-inhibitor.

Ineke G A Wagenaar-Bos1, C Erik Hack.   

Abstract

C1-INH belongs to the family of serpins. Structural studies have yielded a clear understanding of the biochemical principle underlying the functional activities of these proteins. Although the crystal structure of C1-INH has yet to be revealed, homology modeling has provided a three-dimensional model of the serpin part of C1-INH. This model has helped us understand the biochemical consequences of mutations of the C1-INH gene as they occur in patients who have HAE. The structure of the N-terminal domain of C1-INH remains unknown; however, this part of the molecule is unlikely to be important in the inhibitory activity of C1-INH toward its target proteases. Mutations in this part have not been described in patients who have HAE, except for a deletion containing two cysteine residues involved in the stabilization of the serpin domain. Recent studies suggest some anti-inflammatory functions for this N-terminal part, possibly explaining the effects of C1-INH in diseases other than HAE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085281     DOI: 10.1016/j.iac.2006.08.004

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  12 in total

Review 1.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

2.  A serpin that regulates immune melanization in the respiratory system of Drosophila.

Authors:  Huaping Tang; Zakaria Kambris; Bruno Lemaitre; Carl Hashimoto
Journal:  Dev Cell       Date:  2008-10       Impact factor: 12.270

3.  Association between SERPING1 rs2511989 polymorphism and age-related macular degeneration: Meta-analysis.

Authors:  Yi Dong; Ze-Dong Li; Xin-Yu Fang; Xue-Feng Shi; Song Chen; Xin Tang
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

4.  Localization of complement 1 inhibitor (C1INH/SERPING1) in human eyes with age-related macular degeneration.

Authors:  Robert F Mullins; Elizabeth A Faidley; Heather T Daggett; Catherine Jomary; Andrew J Lotery; Edwin M Stone
Journal:  Exp Eye Res       Date:  2009-07-14       Impact factor: 3.467

Review 5.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

6.  The pathophysiology of hereditary angioedema.

Authors:  Bruce L Zuraw
Journal:  World Allergy Organ J       Date:  2010-09       Impact factor: 4.084

Review 7.  Clinical Immunology Review Series: An approach to the patient with angio-oedema.

Authors:  S Grigoriadou; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

Review 8.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

9.  In Search of an Association Between Genotype and Phenotype in Hereditary Angioedema due to C1-INH Deficiency.

Authors:  David Loli-Ausejo; Alberto López-Lera; Christian Drouet; Marina Lluncor; Elsa Phillips-Anglés; María Pedrosa; Rosario Cabañas; Teresa Caballero
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-19       Impact factor: 8.667

Review 10.  Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus.

Authors:  Hilary Longhurst
Journal:  Front Med (Lausanne)       Date:  2018-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.